ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...

Showcase your company news with guaranteed exposure both in print and online Discover how AI and emerging technologies are reshaping businessand the cybersecurity strategies needed to stay… Where ...

VDADX has an exchange-traded version, the Vanguard Dividend Appreciation ETF (VIG, 0.05% expense ratio), that you can buy for ...

This is an important contribution that largely confirms prior evidence that word recognition - a cornerstone of development - improves across early childhood and is related to vocabulary growth. This ...